Other
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
West Pharmaceutical Services Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value increased by 4595.6% to $107.06 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.3%, from $91.28 to $107.06.
Analysis
StatementCash Flow Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Higher values indicate more generous compensation packages or expectations of higher future stock volatility.
Detailed definition
The weighted average fair value of stock options or similar equity awards granted to employees during the period, calcul...
Peer comparison
Standard disclosure; highly dependent on the Black-Scholes or similar valuation models used by the firm.
Metric ID:
other_share_based_compensation_arrangement_by_share_base_1a23a1Historical Data
11 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.19 | $0.53 | $96.50 | $0.16 | $108.80 | $0.08 | $134.81 | $0.12 | $91.28 | $2.28 | $107.06 |
| QoQ Change | — | +178.9% | >999% | -99.8% | >999% | -99.9% | >999% | -99.9% | >999% | -97.5% | >999% |
| YoY Change | — | — | — | -69.8% | +12.7% | — | +23.9% | +50.0% | -32.3% | — | +17.3% |
Range$0.08 – $134.81
CAGR>999%
Avg YoY Growth+0.3%
Median YoY Growth+15.0%
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value?
- West Pharmaceutical Services (WST) reported share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value of $107.06 in Q1 2026.
- How has West Pharmaceutical Services's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value changed year-over-year?
- West Pharmaceutical Services's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value increased by 17.3% year-over-year, from $91.28 to $107.06.
- What does share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value mean?
- The average estimated value of each stock option granted to employees at the time of the grant.